Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||
| Net Income | 21,801 | -316 |
| Depreciation Amortization | 69 | 62 |
| Income taxes - deferred | -4,035 | -684 |
| Accounts receivable | -813 | -489 |
| Accounts payable and accrued liabilities | 437 | 610 |
| Other Working Capital | -32,023 | 21,138 |
| Other Operating Activity | 3,650 | 3,494 |
| Operating Cash Flow | $-10,914 | $23,815 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -964 | -25,435 |
| PPE Investments | -236 | -39 |
| Other Investing Activity | -213 | 0 |
| Investing Cash Flow | $-1,413 | $-25,474 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 1,200 | N/A |
| Debt Repayment | -4,754 | -2,280 |
| Common Stock Issued | 23,898 | 2 |
| Other Financing Activity | -2,923 | 0 |
| Financing Cash Flow | $17,421 | $-2,278 |
| Exchange Rate Effect | -49 | -545 |
| Beginning Cash Position | 17,436 | 21,918 |
| End Cash Position | 22,481 | 17,436 |
| Net Cash Flow | $5,045 | $-4,482 |
| Free Cash Flow | ||
| Operating Cash Flow | -10,914 | 23,815 |
| Capital Expenditure | -236 | -39 |
| Free Cash Flow | -11,150 | 23,776 |